其他专业

Infectious diseases
\r\nOur infectious disease work includes antibacterial and antiviral programs.

\r\n
• Our antibacterial program includes both on-market products as well as products that are in development, including work toward a next-generation gram-negative antibacterial for life-threatening infections.
  \r\n
  \r\n
\r\n
• In antiviral therapies, our work spans hepatitis C (HCV), HIV and COVID-19. With HCV, we are building off our expertise in chronic HCV to find effective therapies for acute HCV so we can help move the world closer toward eliminating this disease.
  \r\n
  \r\n
\r\n
• In HIV, we are pursuing functional cures that can potentially suppress the HIV virus to low levels so that patients have no need for antiretroviral therapy.
  \r\n
  \r\n
\r\n
• We are investigating direct-acting antivirals for the treatment of COVID-19.
  \r\n
  \r\n
\r\n
• Within our pro bono program, more than 400 scientists have given over 170,000 hours of their time toward advancing research and potential medications to treat neglected diseases, including river blindness, Chagas disease and malaria.
\r\n

Pulmonology
\r\nWe have research programs investigating idiopathic pulmonary fibrosis (IPF) and cystic fibrosis. In cystic fibrosis, we are exploring approaches that aim to restore a defected protein into its natural state. In pulmonary fibrosis, we are exploring agents to halt and potentially reverse lung fibrosis.
\r\n
\r\nEndocrinology
\r\nWe focus on conditions linked to hormonal disorders, such as hypothyroidism, hyperparathyroidism, and women's health conditions, such as heavy menstrual bleeding due to uterine fibroids in pre-menopausal women.
\r\n
\r\nTherapeutic neurotoxins
\r\nWe're investigating ways to expand the application of toxins as a medical therapy to reduce the instance of atrial fibrillation following cardiac surgery, as well as a therapy for overactive bladder and interstitial cystitis and bladder pain syndrome.
\r\n
\r\nGastrointestinal tract disorders
\r\nWe are exploring new ways to address diseases of the gastrointestinal tract not related to autoimmune disorders, including pancreatic enzyme replacement therapy and therapies for irritable bowel syndrome with constipation (IBS-C). In each of these, we are also exploring ways to bring therapies to the pediatric population.

我们利用我们的全球经验,创新技术,和协作方法找到答案在不同类型的研究兴趣。了解我们正在努力改善病人的生活质量在以下领域:

传染病
我们的传染病工作包括抗菌和抗病毒程序。

• 抗菌项目包括非市场产品以及产品的开发,包括努力下一代对危及生命的感染革兰氏阴性菌。狗万正网地址
  
  
• 在抗病毒治疗,我们的工作跨越丙型肝炎(丙肝病毒),艾滋病毒和COVID-19。与丙肝病毒,我们正在建设我们的专长在慢性丙肝病毒找到有效治疗急性丙肝病毒我们可以帮助移动世界逼近消除这种疾病。
  
  
• 在艾滋病毒,我们追求功能性治疗可以抑制HIV病毒的低水平,这样的病人不需要抗逆转录病毒治疗。
  
  
• 我们正在调查COVID-19直接的抗病毒药物治疗。
  
  
• 在我们的公益项目,超过400名科学家已经超过170000小时的时间向推进和潜在的药物治疗被忽视疾病的研究,包括河盲症,恰加斯病和疟疾。

肺学
我们有研究项目调查特发性肺纤维化(IPF)和囊性纤维化。在囊性纤维化,我们正在探索方法,旨在恢复叛逃蛋白质进入它的自然状态。在肺纤维化,我们正在探索特工阻止和潜在逆转肺纤维化。

内分泌学
我们关注环境与内分泌紊乱有关,如甲状腺功能减退、甲状旁腺功能亢进,和妇女的健康状况,如沉重的月经出血由于绝经前女性子宫肌瘤。

治疗神经毒素
我们调查的方法扩大应用的毒素作为一种药物治疗减少心脏手术后的房颤的实例,以及治疗膀胱过动症和间质性膀胱炎和膀胱疼痛综合征。

胃肠道疾病
我们正在探索新的方法来解决胃肠道疾病与自身免疫性疾病,包括胰酶替代治疗和治疗肠易激综合征与便秘(IBS-C)。在每一个,我们也探讨如何使治疗小儿人口。